BioMimetic Therapeutics PMA Remains on Track

FRANKLIN, Tenn.--(BUSINESS WIRE)--BMTI completed its 100 day PMA meeting with the FDA regarding the review of Augment™. No unexpected issues were raised that would impact timing. Augment Injectable will be reviewed as medical device.

Film Clips: This weekend's movie openings and more

OPENING FRIDAY ANIMAL KINGDOM 3 stars (R) After his mother’s overdose, teenage J. Cody (James Frecheville) gets pulled into the criminal lifestyle of his uncles (including Ben Mendelsohn and Sullivan Stapleton). With downbeat naturalism, Animal Kingdom refuses to romanticize the Cody gangs’ larcenous activities, emphasizing how the glory days have passed and the Melbourne police are perfectly ...

Appeals court rules game films showing NFL team's 1st logo violates artist's copyright

RICHMOND, Va. - An amateur artist who designed the original logo used by the Baltimore Ravens won a partial victory Thursday when a federal appeals court ruled the commercial use of game and highlight films from the Ravens' first three seasons violates his copyright.

BRINAVESS™ (vernakalant) For Infusion Approved In The European Union For Rapid Conversion Of Recent Onset Atrial ...

Merck (known as MSD outside the United States and Canada) (NYSE:MRK) and Cardiome Pharma Corp. (NASDAQ: CRME/ TSX: COM) announced that the intravenous (IV) formulation of BRINAVESS™ (vernakalant) has been granted marketing approval in the European Union (EU), Iceland and Norway for the rapid conversion of recent onset atrial fibrillation (AF) to sinus rhythm in adults: for non-surgery patients ...

Press Release

Merck and Cardiome Pharma Corp. Posted on:02 Sep 10 Merck (known as MSD outside the United States and Canada) (NYSE:MRK) and Cardiome Pharma Corp. (NASDAQ: CRME/ TSX: COM) today announced that the intravenous (IV) formulation of BRINAVESS™ (vernakalant) has been granted marketing approval in the European Union (EU), Iceland and Norway for the rapid conversion of recent onset atrial fibrillation ...